Potential impact of autoimmune diseases family history in IgG4-related disease: a retrospective cohort study
ObjectiveAutoimmune comorbidities may be associated with IgG4-related disease (IgG4-RD), here we aimed to determine the correlation of autoimmune diseases (AID) family history and IgG4-RD in a Chinese cohort.MethodsThis retrospective cohort study identified 628 cases of IgG4-RD in Peking Union Medic...
Saved in:
Published in | Rheumatic & musculoskeletal diseases open Vol. 9; no. 1; p. e002865 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
EULAR
01.02.2023
BMJ Publishing Group LTD BMJ Publishing Group |
Series | Original research |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ObjectiveAutoimmune comorbidities may be associated with IgG4-related disease (IgG4-RD), here we aimed to determine the correlation of autoimmune diseases (AID) family history and IgG4-RD in a Chinese cohort.MethodsThis retrospective cohort study identified 628 cases of IgG4-RD in Peking Union Medical College Hospital. Patients were classified into two groups, with AID family history group (AID-positive) and without AID family history group (AID-negative). We viewed the potential value of AID family history on IgG4-RD by comparing the differences between the two groups. In addition, Cox regression analysis estimated CIs and HR for IgG4-RD risk.Results93 (14.8%) IgG4-RD patients had AID family history. Compared with AID-negative group, baseline data analysis revealed that AID-positive group patients had an earlier age of IgG4-RD onset (50.4±14.8 vs 54.2±12.6, p=0.014*), a higher percentage of antinuclear antibody (ANA) positivity (38.9% vs 22.7%, p=0.0277*) and Riedel thyroiditis (10.9% vs 2.4%, p=0.001*), were prone to comorbid with other AID (16.1% vs 6.2%, p=0.0238*). Cox analysis found that younger age (HR 0.97 (95% CI 0.94 to 0.99), p=0.0384*) and higher proportions of baseline peripheral eosinophils (HR 1.1 (95% CI 1.02 to 1.2), p=0.0199*) increased the risk of unfavourable prognosis for AID-positive IgG4-RD patients.Conclusions14.8% of IgG4-RD patients had AID family history, with younger age of disease onset age and higher frequency of ANA positivity in AID-positive group, indicating that IgG4-RD may share genetic background with other AID. |
---|---|
AbstractList | Autoimmune comorbidities may be associated with IgG4-related disease (IgG4-RD), here we aimed to determine the correlation of autoimmune diseases (AID) family history and IgG4-RD in a Chinese cohort.
This retrospective cohort study identified 628 cases of IgG4-RD in Peking Union Medical College Hospital. Patients were classified into two groups, with AID family history group (AID-positive) and without AID family history group (AID-negative). We viewed the potential value of AID family history on IgG4-RD by comparing the differences between the two groups. In addition, Cox regression analysis estimated CIs and HR for IgG4-RD risk.
93 (14.8%) IgG4-RD patients had AID family history. Compared with AID-negative group, baseline data analysis revealed that AID-positive group patients had an earlier age of IgG4-RD onset (50.4±14.8 vs 54.2±12.6, p=0.014*), a higher percentage of antinuclear antibody (ANA) positivity (38.9% vs 22.7%, p=0.0277*) and Riedel thyroiditis (10.9% vs 2.4%, p=0.001*), were prone to comorbid with other AID (16.1% vs 6.2%, p=0.0238*). Cox analysis found that younger age (HR 0.97 (95% CI 0.94 to 0.99), p=0.0384*) and higher proportions of baseline peripheral eosinophils (HR 1.1 (95% CI 1.02 to 1.2), p=0.0199*) increased the risk of unfavourable prognosis for AID-positive IgG4-RD patients.
14.8% of IgG4-RD patients had AID family history, with younger age of disease onset age and higher frequency of ANA positivity in AID-positive group, indicating that IgG4-RD may share genetic background with other AID. Objective Autoimmune comorbidities may be associated with IgG4-related disease (IgG4-RD), here we aimed to determine the correlation of autoimmune diseases (AID) family history and IgG4-RD in a Chinese cohort.Methods This retrospective cohort study identified 628 cases of IgG4-RD in Peking Union Medical College Hospital. Patients were classified into two groups, with AID family history group (AID-positive) and without AID family history group (AID-negative). We viewed the potential value of AID family history on IgG4-RD by comparing the differences between the two groups. In addition, Cox regression analysis estimated CIs and HR for IgG4-RD risk.Results 93 (14.8%) IgG4-RD patients had AID family history. Compared with AID-negative group, baseline data analysis revealed that AID-positive group patients had an earlier age of IgG4-RD onset (50.4±14.8 vs 54.2±12.6, p=0.014*), a higher percentage of antinuclear antibody (ANA) positivity (38.9% vs 22.7%, p=0.0277*) and Riedel thyroiditis (10.9% vs 2.4%, p=0.001*), were prone to comorbid with other AID (16.1% vs 6.2%, p=0.0238*). Cox analysis found that younger age (HR 0.97 (95% CI 0.94 to 0.99), p=0.0384*) and higher proportions of baseline peripheral eosinophils (HR 1.1 (95% CI 1.02 to 1.2), p=0.0199*) increased the risk of unfavourable prognosis for AID-positive IgG4-RD patients.Conclusions 14.8% of IgG4-RD patients had AID family history, with younger age of disease onset age and higher frequency of ANA positivity in AID-positive group, indicating that IgG4-RD may share genetic background with other AID. Autoimmune comorbidities may be associated with IgG4-related disease (IgG4-RD), here we aimed to determine the correlation of autoimmune diseases (AID) family history and IgG4-RD in a Chinese cohort.OBJECTIVEAutoimmune comorbidities may be associated with IgG4-related disease (IgG4-RD), here we aimed to determine the correlation of autoimmune diseases (AID) family history and IgG4-RD in a Chinese cohort.This retrospective cohort study identified 628 cases of IgG4-RD in Peking Union Medical College Hospital. Patients were classified into two groups, with AID family history group (AID-positive) and without AID family history group (AID-negative). We viewed the potential value of AID family history on IgG4-RD by comparing the differences between the two groups. In addition, Cox regression analysis estimated CIs and HR for IgG4-RD risk.METHODSThis retrospective cohort study identified 628 cases of IgG4-RD in Peking Union Medical College Hospital. Patients were classified into two groups, with AID family history group (AID-positive) and without AID family history group (AID-negative). We viewed the potential value of AID family history on IgG4-RD by comparing the differences between the two groups. In addition, Cox regression analysis estimated CIs and HR for IgG4-RD risk.93 (14.8%) IgG4-RD patients had AID family history. Compared with AID-negative group, baseline data analysis revealed that AID-positive group patients had an earlier age of IgG4-RD onset (50.4±14.8 vs 54.2±12.6, p=0.014*), a higher percentage of antinuclear antibody (ANA) positivity (38.9% vs 22.7%, p=0.0277*) and Riedel thyroiditis (10.9% vs 2.4%, p=0.001*), were prone to comorbid with other AID (16.1% vs 6.2%, p=0.0238*). Cox analysis found that younger age (HR 0.97 (95% CI 0.94 to 0.99), p=0.0384*) and higher proportions of baseline peripheral eosinophils (HR 1.1 (95% CI 1.02 to 1.2), p=0.0199*) increased the risk of unfavourable prognosis for AID-positive IgG4-RD patients.RESULTS93 (14.8%) IgG4-RD patients had AID family history. Compared with AID-negative group, baseline data analysis revealed that AID-positive group patients had an earlier age of IgG4-RD onset (50.4±14.8 vs 54.2±12.6, p=0.014*), a higher percentage of antinuclear antibody (ANA) positivity (38.9% vs 22.7%, p=0.0277*) and Riedel thyroiditis (10.9% vs 2.4%, p=0.001*), were prone to comorbid with other AID (16.1% vs 6.2%, p=0.0238*). Cox analysis found that younger age (HR 0.97 (95% CI 0.94 to 0.99), p=0.0384*) and higher proportions of baseline peripheral eosinophils (HR 1.1 (95% CI 1.02 to 1.2), p=0.0199*) increased the risk of unfavourable prognosis for AID-positive IgG4-RD patients.14.8% of IgG4-RD patients had AID family history, with younger age of disease onset age and higher frequency of ANA positivity in AID-positive group, indicating that IgG4-RD may share genetic background with other AID.CONCLUSIONS14.8% of IgG4-RD patients had AID family history, with younger age of disease onset age and higher frequency of ANA positivity in AID-positive group, indicating that IgG4-RD may share genetic background with other AID. ObjectiveAutoimmune comorbidities may be associated with IgG4-related disease (IgG4-RD), here we aimed to determine the correlation of autoimmune diseases (AID) family history and IgG4-RD in a Chinese cohort.MethodsThis retrospective cohort study identified 628 cases of IgG4-RD in Peking Union Medical College Hospital. Patients were classified into two groups, with AID family history group (AID-positive) and without AID family history group (AID-negative). We viewed the potential value of AID family history on IgG4-RD by comparing the differences between the two groups. In addition, Cox regression analysis estimated CIs and HR for IgG4-RD risk.Results93 (14.8%) IgG4-RD patients had AID family history. Compared with AID-negative group, baseline data analysis revealed that AID-positive group patients had an earlier age of IgG4-RD onset (50.4±14.8 vs 54.2±12.6, p=0.014*), a higher percentage of antinuclear antibody (ANA) positivity (38.9% vs 22.7%, p=0.0277*) and Riedel thyroiditis (10.9% vs 2.4%, p=0.001*), were prone to comorbid with other AID (16.1% vs 6.2%, p=0.0238*). Cox analysis found that younger age (HR 0.97 (95% CI 0.94 to 0.99), p=0.0384*) and higher proportions of baseline peripheral eosinophils (HR 1.1 (95% CI 1.02 to 1.2), p=0.0199*) increased the risk of unfavourable prognosis for AID-positive IgG4-RD patients.Conclusions14.8% of IgG4-RD patients had AID family history, with younger age of disease onset age and higher frequency of ANA positivity in AID-positive group, indicating that IgG4-RD may share genetic background with other AID. |
Author | Li, Jingna Peng, Linyi Zhou, Jiaxin Lu, Hui Peng, Yu Zeng, Xiaofeng Sun, Ruijie Li, Jieqiong Nie, Yuxue Fei, Yunyun Zhang, Wen Liu, Zheng |
AuthorAffiliation | 2 National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID) , The Ministry of Education Key Laboratory , Beijing , China 1 Department of Rheumatology and Clinical Immunology , Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College , Beijing , China |
AuthorAffiliation_xml | – name: 1 Department of Rheumatology and Clinical Immunology , Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College , Beijing , China – name: 2 National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID) , The Ministry of Education Key Laboratory , Beijing , China |
Author_xml | – sequence: 1 givenname: Ruijie surname: Sun fullname: Sun, Ruijie organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), The Ministry of Education Key Laboratory, Beijing, China – sequence: 2 givenname: Zheng surname: Liu fullname: Liu, Zheng organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), The Ministry of Education Key Laboratory, Beijing, China – sequence: 3 givenname: Hui surname: Lu fullname: Lu, Hui organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), The Ministry of Education Key Laboratory, Beijing, China – sequence: 4 givenname: Yu surname: Peng fullname: Peng, Yu organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), The Ministry of Education Key Laboratory, Beijing, China – sequence: 5 givenname: Jieqiong surname: Li fullname: Li, Jieqiong organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), The Ministry of Education Key Laboratory, Beijing, China – sequence: 6 givenname: Yuxue surname: Nie fullname: Nie, Yuxue organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), The Ministry of Education Key Laboratory, Beijing, China – sequence: 7 givenname: Jingna surname: Li fullname: Li, Jingna organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), The Ministry of Education Key Laboratory, Beijing, China – sequence: 8 givenname: Linyi surname: Peng fullname: Peng, Linyi organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), The Ministry of Education Key Laboratory, Beijing, China – sequence: 9 givenname: Jiaxin orcidid: 0000-0002-1664-3495 surname: Zhou fullname: Zhou, Jiaxin email: pumczhou@sina.com organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), The Ministry of Education Key Laboratory, Beijing, China – sequence: 10 givenname: Yunyun surname: Fei fullname: Fei, Yunyun organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), The Ministry of Education Key Laboratory, Beijing, China – sequence: 11 givenname: Xiaofeng surname: Zeng fullname: Zeng, Xiaofeng organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), The Ministry of Education Key Laboratory, Beijing, China – sequence: 12 givenname: Wen orcidid: 0000-0001-7808-9867 surname: Zhang fullname: Zhang, Wen email: zhangwen91@sina.com organization: National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), The Ministry of Education Key Laboratory, Beijing, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36759004$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkktv1DAUhSNUREvpL0BCltiwCXX8SswCCVVQRqoEC1hbN_bNjEdJPNhOpfn3JMy0tF3Aypb9naP7OC-LkzGMWBSvK_q-qri6jIMLOxxLRhkrKWWNks-KM0alKqXm_OTB_bS4SGlLKa0E53XFXxSnXNVSUyrOiv57yDhmDz3xww5sJqEjMOXgh2EakTifEBIm0sHg-z3Z-JRD3BM_ktX6WpQRe8jo7rgPBEjEHEPaoc3-FokNmxAzSXly-1fF8w76hBfH87z4-eXzj6uv5c2369XVp5uylVznkmsHLUPLnGuUknWnEKSzzNaOi65ZGml0BVKBcNzyBjUXEmTVQgeinbs8L1YHXxdga3bRDxD3JoA3fx5CXBuI2dseDToO1DYWkNVCW6atBJCdk7WQHdWL18eD125qB3R2HlaE_pHp45_Rb8w63BqtGedSzQbvjgYx_JowZTP4ZLHvYcQwJcPqWiomeK1n9O0TdBumOM6jWiihKJ_nMVNvHlZ0X8rdUmeAHwA77yFF7O6RipolPeaYHrOkxxzSM6v0E5X1GbIPS1u-_4_28qBth-3fmv-l-A0vnt1x |
CitedBy_id | crossref_primary_10_1016_j_ejim_2023_08_014 crossref_primary_10_1053_j_semdp_2023_11_005 crossref_primary_10_3390_biomedicines11061691 |
Cites_doi | 10.1038/nrrheum.2016.52 10.1111/all.12320 10.1093/rheumatology/keaa651 10.1002/hep.26999 10.1002/acr.23543 10.1093/rheumatology/kex005 10.1016/j.jaci.2021.05.002 10.1136/ard.60.3.223 10.1186/s13073-021-00853-7 10.1016/j.jtauto.2020.100047 10.1016/S0140-6736(13)60954-X 10.1007/82_2016_37 10.1126/scitranslmed.aaq0997 10.1093/rheumatology/key397 10.1093/rheumatology/kew500 10.1186/s12888-022-04298-z 10.4103/0366-6999.184459 10.1111/joim.12942 10.1056/NEJMra1104650 10.1002/acr.22366 10.1136/annrheumdis-2019-216561 10.19723/j.issn.1671-167X.2019.03.010 10.1038/nrrheum.2010.23 10.1016/j.lanepe.2022.100417 10.1136/ard.2008.089169 10.3748/wjg.v16.i41.5241 10.1111/j.1365-3083.2010.02453.x 10.1016/S0140-6736(14)60720-0 10.1186/s12967-022-03606-1 10.1016/s0895-4356(02)00429-8 10.1002/acr.24115 10.1016/S0895-4356(02)00429-8 |
ContentType | Journal Article |
Copyright | Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 |
Copyright_xml | – notice: Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 |
DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BTHHO CCPQU DWQXO FYUFA GHDGH K9. PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1136/rmdopen-2022-002865 |
DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central BMJ Journals ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition BMJ Journals ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2056-5933 |
ExternalDocumentID | oai_doaj_org_article_ed3a0c8cae2749c29c5aa5fd5745f094 PMC9923356 36759004 10_1136_rmdopen_2022_002865 rmdopen |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GrantInformation_xml | – fundername: Beijing Municipal Science & Technology Commission grantid: Z201100005520023 – fundername: Capital’s Funds for Health Improvement and Research grantid: No. 2020-2-4017 – fundername: CAMS grantid: CIFMS 2021-1-I2M-003 – fundername: National Natural Science Foundation of China grantid: 81771757; 82071839 funderid: http://dx.doi.org/10.13039/501100001809 – fundername: ; grantid: Z201100005520023 – fundername: ; grantid: No. 2020-2-4017 – fundername: ; grantid: 81771757; 82071839 – fundername: ; grantid: CIFMS 2021-1-I2M-003 |
GroupedDBID | 53G 5VS 7X7 8FI 8FJ 9YT ABUWG ACMMV ADBBV AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV BENPR BTFSW BTHHO CCPQU DIK EBS EJD FYUFA GROUPED_DOAJ H13 HMCUK HYE HZ~ KQ8 M48 M~E O9- OK1 PGMZT PHGZT PIMPY PQQKQ PROAC RHI RMJ RPM UKHRP AAYXX ADRAZ CITATION PHGZM PJZUB PPXIY 3V. CGR CUY CVF ECM EIF NPM RHF 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-b539t-39dab2ec2dd86657f6ea5dc2c7d34f80014891a56a4d3c38e9345a51bafa4b143 |
IEDL.DBID | M48 |
ISSN | 2056-5933 |
IngestDate | Wed Aug 27 00:50:52 EDT 2025 Thu Aug 21 18:38:11 EDT 2025 Thu Jul 10 18:48:01 EDT 2025 Fri Jul 25 09:58:04 EDT 2025 Thu Jan 02 22:54:13 EST 2025 Thu Aug 21 00:36:01 EDT 2025 Thu Apr 24 22:52:59 EDT 2025 Thu Apr 24 22:49:56 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | autoimmune diseases immune system diseases |
Language | English |
License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b539t-39dab2ec2dd86657f6ea5dc2c7d34f80014891a56a4d3c38e9345a51bafa4b143 |
Notes | Original research ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-1664-3495 0000-0001-7808-9867 |
OpenAccessLink | https://doaj.org/article/ed3a0c8cae2749c29c5aa5fd5745f094 |
PMID | 36759004 |
PQID | 2774603866 |
PQPubID | 2041888 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ed3a0c8cae2749c29c5aa5fd5745f094 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9923356 proquest_miscellaneous_2775624379 proquest_journals_2774603866 pubmed_primary_36759004 crossref_primary_10_1136_rmdopen_2022_002865 crossref_citationtrail_10_1136_rmdopen_2022_002865 bmj_journals_10_1136_rmdopen_2022_002865 |
PublicationCentury | 2000 |
PublicationDate | 2023-02-01 |
PublicationDateYYYYMMDD | 2023-02-01 |
PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
PublicationSeriesTitle | Original research |
PublicationTitle | Rheumatic & musculoskeletal diseases open |
PublicationTitleAbbrev | RMD Open |
PublicationTitleAlternate | RMD Open |
PublicationYear | 2023 |
Publisher | EULAR BMJ Publishing Group LTD BMJ Publishing Group |
Publisher_xml | – name: EULAR – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
References | Hirano, Tada, Isayama (R25) 2010; 16 van Toorenenbergen, van Heerde, van Buuren (R26) 2010; 72 Hong, Li, Su (R9) 2015; 18 de Buy Wenniger, Culver, Beuers (R32) 2014; 60 Plichta, Somani, Pichaud (R3) 2021; 13 Ulff-Møller, Simonsen, Kyvik (R18) 2017; 56 Lu, Teng, Zhang (R23) 2021; 60 Nyberg, Batty, Pentti (R7) 2022; 19 Chen, Zhao, Feng (R8) 2016; 129 Kochi, Suzuki, Yamada (R11) 2010; 6 Masaki, Dong, Kurose (R24) 2009; 68 Tian, Zhang, Jiang (R6) 2022; 22 Ota, Umemura, Kawa (R30) 2017; 401 Wallace, Naden, Chari (R4) 2020; 79 Kronzer, Crowson, Sparks (R16) 2021; 73 Wallace, Khosroshahi, Carruthers (R5) 2018; 70 Wahren-Herlenius, Dörner (R12) 2013; 382 Stone, Zen, Deshpande (R1) 2012; 366 Wang, Zhang, Zhang (R29) 2019; 58 Della Torre, Mattoo, Mahajan (R27) 2014; 69 Kuo, Grainge, Valdes (R14) 2017; 56 Lu, Wu, Peng (R10) 2022; 20 Liu, Zhang, Zhang (R19) 2020; 3 Zhang, Jin, He (R22) 2019; 51 Kamisawa, Zen, Pillai (R2) 2015; 385 Peng, Li, Zhang (R28) 2019; 286 Frisell, Saevarsdottir, Askling (R13) 2016; 12 Cooper, Dooley, Treadwell (R17) 2002; 55 Sparks, Chen, Hiraki (R15) 2014; 66 Hutchinson, Shepstone, Moots (R31) 2001; 60 Jarrell, Baker, Perugino (R20) 2022; 149 Shiokawa, Kodama, Sekiguchi (R21) 2018; 10 2025081710175131000_9.1.e002865.27 2025081710175131000_9.1.e002865.28 Nyberg (2025081710175131000_9.1.e002865.7) 2022; 19 2025081710175131000_9.1.e002865.29 Zhang (2025081710175131000_9.1.e002865.22) 2019; 51 Ulff-Møller (2025081710175131000_9.1.e002865.18) 2017; 56 2025081710175131000_9.1.e002865.24 2025081710175131000_9.1.e002865.1 2025081710175131000_9.1.e002865.2 Jarrell (2025081710175131000_9.1.e002865.20) 2022; 149 Sparks (2025081710175131000_9.1.e002865.15) 2014; 66 Lu (2025081710175131000_9.1.e002865.10) 2022; 20 Liu (2025081710175131000_9.1.e002865.19) 2020; 3 Tian (2025081710175131000_9.1.e002865.6) 2022; 22 2025081710175131000_9.1.e002865.17 Wallace (2025081710175131000_9.1.e002865.5) 2018; 70 Lu (2025081710175131000_9.1.e002865.23) 2021; 60 2025081710175131000_9.1.e002865.31 2025081710175131000_9.1.e002865.32 2025081710175131000_9.1.e002865.8 2025081710175131000_9.1.e002865.11 2025081710175131000_9.1.e002865.12 Shiokawa (2025081710175131000_9.1.e002865.21) 2018; 10 2025081710175131000_9.1.e002865.13 Hong (2025081710175131000_9.1.e002865.9) 2015; 18 2025081710175131000_9.1.e002865.4 Hirano (2025081710175131000_9.1.e002865.25) 2010; 16 Ota (2025081710175131000_9.1.e002865.30) 2017; 401 Plichta (2025081710175131000_9.1.e002865.3) 2021; 13 van Toorenenbergen (2025081710175131000_9.1.e002865.26) 2010; 72 Kuo (2025081710175131000_9.1.e002865.14) 2017; 56 Kronzer (2025081710175131000_9.1.e002865.16) 2021; 73 |
References_xml | – volume: 12 start-page: 335 year: 2016 ident: R13 article-title: Family history of rheumatoid arthritis: an old concept with new developments publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2016.52 – volume: 69 start-page: 269 year: 2014 ident: R27 article-title: Prevalence of atopy, eosinophilia, and ige elevation in igg4-related disease publication-title: Allergy doi: 10.1111/all.12320 – volume: 60 start-page: 2635 year: 2021 ident: R23 article-title: Differences in clinical characteristics of igg4-related disease across age groups: a prospective study of 737 patients publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keaa651 – volume: 60 start-page: 1453 year: 2014 ident: R32 article-title: Exposure to occupational antigens might predispose to igg4-related disease publication-title: Hepatology doi: 10.1002/hep.26999 – volume: 70 start-page: 1671 year: 2018 ident: R5 article-title: An international multispecialty validation study of the igg4-related disease responder index publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.23543 – volume: 56 start-page: 957 year: 2017 ident: R18 article-title: Family history of systemic lupus erythematosus and risk of autoimmune disease: nationwide cohort study in denmark 1977-2013 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kex005 – volume: 149 start-page: 358 year: 2022 ident: R20 article-title: Neutralizing anti-IL-1 receptor antagonist autoantibodies induce inflammatory and fibrotic mediators in igg4-related disease publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2021.05.002 – volume: 60 start-page: 223 year: 2001 ident: R31 article-title: Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA publication-title: Ann Rheum Dis doi: 10.1136/ard.60.3.223 – volume: 13 year: 2021 ident: R3 article-title: Congruent microbiome signatures in fibrosis-prone autoimmune diseases: igg4-related disease and systemic sclerosis publication-title: Genome Med doi: 10.1186/s13073-021-00853-7 – volume: 3 year: 2020 ident: R19 article-title: Immunological mechanism of igg4-related disease publication-title: J Transl Autoimmun doi: 10.1016/j.jtauto.2020.100047 – volume: 18 start-page: 85 year: 2015 ident: R9 article-title: Internal organ involvement in igg4-related sialadenitis: a systemic review publication-title: Chin J Dent Res – volume: 382 start-page: 819 year: 2013 ident: R12 article-title: Immunopathogenic mechanisms of systemic autoimmune disease publication-title: Lancet doi: 10.1016/S0140-6736(13)60954-X – volume: 401 start-page: 35 year: 2017 ident: R30 article-title: Immunogenetics of igg4-related AIP publication-title: Curr Top Microbiol Immunol doi: 10.1007/82_2016_37 – volume: 10 year: 2018 ident: R21 article-title: Laminin 511 is a target antigen in autoimmune pancreatitis publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aaq0997 – volume: 58 start-page: 820 year: 2019 ident: R29 article-title: Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/key397 – volume: 56 start-page: 928 year: 2017 ident: R14 article-title: Familial aggregation of rheumatoid arthritis and co-aggregation of autoimmune diseases in affected families: a nationwide population-based study publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kew500 – volume: 22 year: 2022 ident: R6 article-title: Association of alcohol use with memory decline in middle-aged and older chinese: a longitudinal cohort study publication-title: BMC Psychiatry doi: 10.1186/s12888-022-04298-z – volume: 129 start-page: 1525 year: 2016 ident: R8 article-title: Types of organ involvement in patients with immunoglobulin G4-related disease publication-title: Chin Med J (Engl) doi: 10.4103/0366-6999.184459 – volume: 286 start-page: 542 year: 2019 ident: R28 article-title: Clinical outcomes and predictive relapse factors of igg4-related disease following treatment: a long-term cohort study publication-title: J Intern Med doi: 10.1111/joim.12942 – volume: 366 start-page: 539 year: 2012 ident: R1 article-title: IgG4-related disease publication-title: N Engl J Med doi: 10.1056/NEJMra1104650 – volume: 66 start-page: 1438 year: 2014 ident: R15 article-title: Contributions of familial rheumatoid arthritis or lupus and environmental factors to risk of rheumatoid arthritis in women: a prospective cohort study publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.22366 – volume: 79 start-page: 77 year: 2020 ident: R4 article-title: The 2019 american college of rheumatology/european league against rheumatism classification criteria for igg4-related disease publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2019-216561 – volume: 51 start-page: 439 year: 2019 ident: R22 article-title: Family history of rheumatic diseases in patients with rheumatoid arthritis: a large scale cross-sectional study publication-title: Beijing Da Xue Xue Bao Yi Xue Ban doi: 10.19723/j.issn.1671-167X.2019.03.010 – volume: 6 start-page: 290 year: 2010 ident: R11 article-title: Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2010.23 – volume: 19 year: 2022 ident: R7 article-title: Association of alcohol use with years lived without major chronic diseases: a multicohort study from the IPD-work consortium and UK biobank publication-title: Lancet Reg Health Eur doi: 10.1016/j.lanepe.2022.100417 – volume: 68 start-page: 1310 year: 2009 ident: R24 article-title: Proposal for a new clinical entity, igg4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of igg4-related disorders publication-title: Ann Rheum Dis doi: 10.1136/ard.2008.089169 – volume: 16 start-page: 5241 year: 2010 ident: R25 article-title: Clinical analysis of high serum ige in autoimmune pancreatitis publication-title: World J Gastroenterol doi: 10.3748/wjg.v16.i41.5241 – volume: 72 start-page: 444 year: 2010 ident: R26 article-title: Potential value of serum total ige for differentiation between autoimmune pancreatitis and pancreatic cancer publication-title: Scand J Immunol doi: 10.1111/j.1365-3083.2010.02453.x – volume: 385 start-page: 1460 year: 2015 ident: R2 article-title: IgG4-related disease publication-title: Lancet doi: 10.1016/S0140-6736(14)60720-0 – volume: 20 year: 2022 ident: R10 article-title: TSLP promoting B cell proliferation and polarizing follicular helper T cell as a therapeutic target in igg4-related disease publication-title: J Transl Med doi: 10.1186/s12967-022-03606-1 – volume: 55 start-page: 982 year: 2002 ident: R17 article-title: Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history publication-title: J Clin Epidemiol doi: 10.1016/s0895-4356(02)00429-8 – volume: 73 start-page: 180 year: 2021 ident: R16 article-title: Family history of rheumatic, autoimmune, and nonautoimmune diseases and risk of rheumatoid arthritis publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.24115 – ident: 2025081710175131000_9.1.e002865.2 doi: 10.1016/S0140-6736(14)60720-0 – ident: 2025081710175131000_9.1.e002865.13 doi: 10.1038/nrrheum.2016.52 – volume: 70 start-page: 1671 year: 2018 ident: 2025081710175131000_9.1.e002865.5 article-title: An international multispecialty validation study of the igg4-related disease responder index publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.23543 – ident: 2025081710175131000_9.1.e002865.8 doi: 10.4103/0366-6999.184459 – volume: 51 start-page: 439 year: 2019 ident: 2025081710175131000_9.1.e002865.22 article-title: Family history of rheumatic diseases in patients with rheumatoid arthritis: a large scale cross-sectional study publication-title: Beijing Da Xue Xue Bao Yi Xue Ban – volume: 10 year: 2018 ident: 2025081710175131000_9.1.e002865.21 article-title: Laminin 511 is a target antigen in autoimmune pancreatitis publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aaq0997 – volume: 3 year: 2020 ident: 2025081710175131000_9.1.e002865.19 article-title: Immunological mechanism of igg4-related disease publication-title: J Transl Autoimmun doi: 10.1016/j.jtauto.2020.100047 – volume: 66 start-page: 1438 year: 2014 ident: 2025081710175131000_9.1.e002865.15 article-title: Contributions of familial rheumatoid arthritis or lupus and environmental factors to risk of rheumatoid arthritis in women: a prospective cohort study publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.22366 – ident: 2025081710175131000_9.1.e002865.4 doi: 10.1136/annrheumdis-2019-216561 – ident: 2025081710175131000_9.1.e002865.24 doi: 10.1136/ard.2008.089169 – volume: 73 start-page: 180 year: 2021 ident: 2025081710175131000_9.1.e002865.16 article-title: Family history of rheumatic, autoimmune, and nonautoimmune diseases and risk of rheumatoid arthritis publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.24115 – volume: 401 start-page: 35 year: 2017 ident: 2025081710175131000_9.1.e002865.30 article-title: Immunogenetics of igg4-related AIP publication-title: Curr Top Microbiol Immunol – ident: 2025081710175131000_9.1.e002865.1 doi: 10.1056/NEJMra1104650 – volume: 19 year: 2022 ident: 2025081710175131000_9.1.e002865.7 article-title: Association of alcohol use with years lived without major chronic diseases: a multicohort study from the IPD-work consortium and UK biobank publication-title: Lancet Reg Health Eur doi: 10.1016/j.lanepe.2022.100417 – volume: 18 start-page: 85 year: 2015 ident: 2025081710175131000_9.1.e002865.9 article-title: Internal organ involvement in igg4-related sialadenitis: a systemic review publication-title: Chin J Dent Res – volume: 16 start-page: 5241 year: 2010 ident: 2025081710175131000_9.1.e002865.25 article-title: Clinical analysis of high serum ige in autoimmune pancreatitis publication-title: World J Gastroenterol doi: 10.3748/wjg.v16.i41.5241 – volume: 13 year: 2021 ident: 2025081710175131000_9.1.e002865.3 article-title: Congruent microbiome signatures in fibrosis-prone autoimmune diseases: igg4-related disease and systemic sclerosis publication-title: Genome Med doi: 10.1186/s13073-021-00853-7 – volume: 56 start-page: 957 year: 2017 ident: 2025081710175131000_9.1.e002865.18 article-title: Family history of systemic lupus erythematosus and risk of autoimmune disease: nationwide cohort study in denmark 1977-2013 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kex005 – ident: 2025081710175131000_9.1.e002865.27 doi: 10.1111/all.12320 – ident: 2025081710175131000_9.1.e002865.29 doi: 10.1093/rheumatology/key397 – volume: 149 start-page: 358 year: 2022 ident: 2025081710175131000_9.1.e002865.20 article-title: Neutralizing anti-IL-1 receptor antagonist autoantibodies induce inflammatory and fibrotic mediators in igg4-related disease publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2021.05.002 – ident: 2025081710175131000_9.1.e002865.28 doi: 10.1111/joim.12942 – volume: 20 year: 2022 ident: 2025081710175131000_9.1.e002865.10 article-title: TSLP promoting B cell proliferation and polarizing follicular helper T cell as a therapeutic target in igg4-related disease publication-title: J Transl Med doi: 10.1186/s12967-022-03606-1 – volume: 56 start-page: 928 year: 2017 ident: 2025081710175131000_9.1.e002865.14 article-title: Familial aggregation of rheumatoid arthritis and co-aggregation of autoimmune diseases in affected families: a nationwide population-based study publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kew500 – volume: 72 start-page: 444 year: 2010 ident: 2025081710175131000_9.1.e002865.26 article-title: Potential value of serum total ige for differentiation between autoimmune pancreatitis and pancreatic cancer publication-title: Scand J Immunol doi: 10.1111/j.1365-3083.2010.02453.x – ident: 2025081710175131000_9.1.e002865.17 doi: 10.1016/S0895-4356(02)00429-8 – ident: 2025081710175131000_9.1.e002865.12 doi: 10.1016/S0140-6736(13)60954-X – ident: 2025081710175131000_9.1.e002865.11 doi: 10.1038/nrrheum.2010.23 – volume: 60 start-page: 2635 year: 2021 ident: 2025081710175131000_9.1.e002865.23 article-title: Differences in clinical characteristics of igg4-related disease across age groups: a prospective study of 737 patients publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keaa651 – volume: 22 year: 2022 ident: 2025081710175131000_9.1.e002865.6 article-title: Association of alcohol use with memory decline in middle-aged and older chinese: a longitudinal cohort study publication-title: BMC Psychiatry doi: 10.1186/s12888-022-04298-z – ident: 2025081710175131000_9.1.e002865.31 doi: 10.1136/ard.60.3.223 – ident: 2025081710175131000_9.1.e002865.32 doi: 10.1002/hep.26999 |
SSID | ssj0001433713 |
Score | 2.2439175 |
Snippet | ObjectiveAutoimmune comorbidities may be associated with IgG4-related disease (IgG4-RD), here we aimed to determine the correlation of autoimmune diseases... Autoimmune comorbidities may be associated with IgG4-related disease (IgG4-RD), here we aimed to determine the correlation of autoimmune diseases (AID) family... Objective Autoimmune comorbidities may be associated with IgG4-related disease (IgG4-RD), here we aimed to determine the correlation of autoimmune diseases... |
SourceID | doaj pubmedcentral proquest pubmed crossref bmj |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e002865 |
SubjectTerms | Alcohol use Autoimmune diseases Autoinflammatory Disorders Bile ducts Cohort analysis Coronary vessels Disease Exocrine glands Families & family life Family medical history Hashimoto Disease Health risk assessment Humans immune system diseases Immunoglobulin G Immunoglobulin G4-Related Disease - diagnosis Immunoglobulin G4-Related Disease - epidemiology Laboratories Lupus Pancreatitis Pathogenesis Patients Pituitary gland Prognosis Psoriasis Remission (Medicine) Retrospective Studies Rheumatoid arthritis Statistical analysis Thyroid gland Variables |
SummonAdditionalLinks | – databaseName: BMJ Open Access Journals dbid: 9YT link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3Nb9UwDLfGkBAXxDeFgYLEgQPdW-skbbgBYgykIQ6bNE6Vm6TbQ1uLur4D_z1O077xEJo4tnWixB-NncQ_A7xyWhobUpRt5imVVOjUeFmyLteyIcpN2YRE4cOv-uBYfjlRJ1uwN-fC9BculI3arS9-xIyGgNHUDguzyBY-BAha7YaN6RtwM5QmCZe4zPejq10Vichh1wQvlKGeO2Rt4KgrdsDLCHe_sRCNeP3_cjL_viv5x-KzfxfuTF6jeBfFfA-2fHsfbh1O5-IP4PxbF8bPuiRi2qPoGkGroVuG9A8vpmOYSxH3M0REGf4llq34fPpJpmNGi3cz3VtBovdD3815mCLU0e0HMYLRPoTj_Y9HHw7SqY5CWis0Q4rGUZ17mzsX0O2KRntSzua2cCibMnCtNBkpTdKhxdIblIpUVlNDsmaWPoLttmv9ExCEHpF9lpyUlI4KY1VGpmanDTFrJCbwmllbTXZwWY0hBupqkkIVpFBFKSSQz_yv7IRHHspinF_f6M260c8Ix3E9-fsg2DVpwNIeX3T9aTWZZuUd0p4tLXmO0I3NeU5EqnGqkKrh6DeBnVktriaWs9us95D5mcDL9Wc2zXDeQq3vViMNe5cB8DGBx1GL1iNBDtQM_6ASKDb0a2Oom1_a5dkI_23YJ0eln_4_q5_BbX7CeNl8B7aHfuWfsy811C9G8_kNfcUd1w priority: 102 providerName: BMJ Publishing Group Ltd – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9UwDI_QDogL4puygYLEgQPV1jpJG25sYgykIQ5M2q1y8wEPbe3U9R3473E-3uM9hMaFa-NIie3EdmP_zNgrq4Q2oUTZVA5LgY0qtRMt6XIvPGKtWx8KhU8_q5Mz8elcnm-0-go5YQkeODFu31nAA9MadBQ_aVNrIxGlt7IR0lNsEm5fsnkbwVT8uyIAKPzKMEMVqP3p0oZ-VKQVFH2FSCOak_7yx5ZBirj9f3M2_8yZ3DBCx_fY3ew98ndp1ffZLTc8YLdP8_v4Q3bxZZxD-g_RpPJHPnqOy3lchDIQx_NzzDVP_zV4Qhv-yRcD__jtgyhjZYuzK7q3HPnk5mlc1WPy0E93mnkEpX3Ezo7ffz06KXM_hbKXoOcStMW-dqa2NqDcNV45lNbUprEgfBu41uoKpUJhwUDrNAiJsurRo-iJpY_ZzjAO7injCA6AfJcapRAWG5JKhbon5w2g8gIK9ppY2-XzcN3FUANUl6XQBSl0SQoFq1f870zGJQ_tMS5unvRmPekqwXLcTH4YBLsmDZja8QNpWpc1rfuXphVsb6UWvzdWk_usDoD4WbCX62E6ouHdBQc3LiMNeZkB-LFgT5IWrVcCFLBpuqgK1mzp19ZSt0eGxfcIA67JNwepnv2Pve2yO8QuSOnoe2xnnpbuOXlbc_8iHqxfJdMpug priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDI9gSIgXxDcdAwWJBx6ottZJ2vCCADEG0hAPTLq3yk3ScWhrt17vgf8eu83dcQjda-NIqe0kdmz_LMQrb5R1XKLssoCpwsKkNqiSdLlWDWJuy4YLhU-_mZMz9XWmZ_HBbRHTKldn4nhQ-87xG_lhTnaKOYLSmHdX1yl3jeLoamyhcVPcYugyTukqZsXmjUUBkBMWwYYyMIf9peeuVKQb5IOxvzFeKvXlr61raUTv_5_J-W_m5F9X0fE9cTfakPL9JPT74kZoH4jbpzFK_lBcfO8GTgIimqkIUnaNxOXQzbkYJMgYlFnI6XVDTpjDv-W8lV_OP6t0rG8JfkX3VqLsw9B3q6pMyV11-0GO0LSPxNnxpx8fT9LYVSGtNdghBeuxzoPLvWesu6IxAbV3uSs8qKZkrpU2Q21QeXBQBgtKo85qbFDVxNLHYq_t2vBUSIQAQBZMjlopj4V1OkNbkwkHkDUKEvGaWFvFXbGoRocDTBWlULEUqkkKichX_K9cRCfnJhkXuye9WU-6msA5dpN_YMGuSRlZe_zQ9edV3KhV8IBHrnQYyF-3Lqd_QtSN14XSDfnCiThYqcXmxzbKmYiX62HaqBx9wTZ0y5GGbE2Gf0zEk0mL1isBctssHVeJKLb0a2up2yPt_OcIBm7JQgdt9ncv65m4Q4yAKd38QOwN_TI8J2tqqF-MW-YPZYogaw priority: 102 providerName: ProQuest |
Title | Potential impact of autoimmune diseases family history in IgG4-related disease: a retrospective cohort study |
URI | https://rmdopen.bmj.com/content/9/1/e002865.full https://www.ncbi.nlm.nih.gov/pubmed/36759004 https://www.proquest.com/docview/2774603866 https://www.proquest.com/docview/2775624379 https://pubmed.ncbi.nlm.nih.gov/PMC9923356 https://doaj.org/article/ed3a0c8cae2749c29c5aa5fd5745f094 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_tQ0K8IL4JjMpIPPBAYI3tJEZCaJs2BlKnCa1oPEUX2xlFXQJZKrH_nrPjFIrGJF5aNb5Ezn307mzf7wCem1Qo7UqU9dhiLDBLY2VFTrpcigoxUXnlCoUnR-nhVHw8ladrMHRFDQy8uDK1c_2kpu381c8fl-_I4N-GjiSv23PjhkjglFi5JCKV67BJrilzljoJ8b5fdBGcZ75lckKOP5aUzQckon88hzxOef5txWd5aP-r4tG_j1X-4acObsOtEGCynV4j7sCare_CjUnYQr8H8-OmcyeEiKavkGRNxXDRNTNXKWJZ2LG5YP3SB-sBiS_ZrGYfzt6L2Be_WDPQvWHIWtu1zVCyyVzL3bZjHrf2PkwP9k_2DuPQciEuJVddzJXBMrE6McYB4WVValEanejMcFHljoO5GqNMURiueW4VFxLluMQKRUnsfQAbdVPbR8CQW84pvElQCmEwU1qOUZUU33E-rgSP4AWxthgkXvhshKdFkELhpFD0UoggGfhf6ABd7jpozK-_6eXypu89csf15LtOsEtSB7vtLzTtWRGsuLCG47bONVpK5pVO6J0QZWVkJmRFiXIEW4Na_H6xhCLsdJsTPyN4thwmK3ZbM1jbZuFpKBB12JARPOy1aDkTTjmdov-yCLIV_VqZ6upIPfvqkcIVhe9cpo__jxVP4Cb94v3Z9C3Y6NqFfUqhV1eOYD07zehTfTkZwebO3mTymb5394-OP438csbIG9wvdcAyDA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJwEviDuBAUYCiQeiLT62EyMhxGCjZWs1oU3aW3BsZxRtyUhTof0pfiPHubQUob3ttTmpHJ-Lz2f7fIeQl1ZyZXyJsomcDrmOZagcT9CWM55rzVSS-0Lh8UQOj_iXY3G8Rn73tTD-WmUfE5tAbUvj98g3GeYpcgsSKd-f_wx91yh_utq30GjNYs9d_ELINns3-oT6fcXY7s7hx2HYdRUIMwGqDkFZnTFnmLWe6y3OpdPCGmZiCzxPPGZIVKSF1NyCgcQp4EKLKNO55hmmF_i_18g6B4QyA7K-vTM5-Lrc1eEACPs6eqMI5GZ1Zn0fLLRGRH0e4TTLWHb2Y2UhbPoF_C_J_feu5l-L3-5tcqvLWumH1szukDVX3CXXx925_D1yelDW_toRyrRll7TMqZ7X5dSXnzjaHQPNaLufQluW4ws6Lejo5DMPm4oaZ3u5t1TTytVV2deBUt_Ht6ppQ4Z7nxxdyYw_IIOiLNwjQjU4AMyZmBacWx0rIyKtMkwaAaKcQ0Be49SmnR_O0gbigEw7LaReC2mrhYCwfv5T0_Gh-7Ycp5e_9Gbx0nlLB3K5-LZX7ELUc3k3P5TVSdqFhtRZ0FsmMdqxGB2H4TdpLXIrYi5yRN8B2ejNYvlhS3cIyIvFYwwN_rxHF66cNzKY3XrCyYA8bK1oMRJAoKgwQAYkXrGvlaGuPimm3xv6cYWYAIR8fPmwnpMbw8Pxfro_muw9ITdxUqC97L5BBnU1d08xl6uzZ50DUfLtqn32D7jGXyg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSouiDeBAkYCiQPRNh47iZEQAsrSpbTqgUp7Sye2Uxa1SdnNCvWv8esY57HLIrS3XpNx5HgenrFnvmHshY2lNr5E2UQOQ4lJHGonU5LlXBaIQqeFLxQ-OIz3juWXsRpvsN99LYxPq-xtYmOobWX8GflAkJ8S70Aax4OiS4s42h2-u_gZ-g5S_qa1b6fRisi-u_xF4dvs7WiXeP1SiOGnbx_3wq7DQJgr0HUI2mIunBHWety3pIgdKmuESSzIIvXxQ6ojVDFKCwZSp0EqVFGOBcqcXA367jV2PQEVeR1LxsnyfEcCUADYAR1FEA-m59Z3xCK5pPjPxzrNhpaf_1jZEpvOAf9zd__N2vxrGxzeYjc7_5W_bwXuNttw5R22ddDd0N9lZ0dV7ROQiKYtwORVwXFeVxNfiOJ4dyE04-3JCm_xji_5pOSj088ybGprnO3p3nDkU1dPq74ilPuOvtOaN7C499jxlaz3fbZZVqV7yDiCAyDvSaCS0mKijYpQ5-Q-AkSFhIC9oqXNOo2cZU2wA3HWcSHzXMhaLgRM9OufmQ4Z3TfoOFs_6PVi0EULDLKe_INn7ILUo3o3D6rpadYZicxZwB2TGnQiIRUS9E-IqrAqkaqgODxg271YLH9sqRgBe754TUbC3_xg6ap5Q0N-roeeDNiDVooWMwEKGTWZyoAlK_K1MtXVN-XkewNErik6ABU_Wj-tZ2yLNDX7Ojrcf8xu0JpAm_W-zTbr6dw9Iaeuzp822sPZyVWr6x8DF2H4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Potential+impact+of+autoimmune+diseases+family+history+in+IgG4-related+disease%3A+a+retrospective+cohort+study&rft.jtitle=Rheumatic+%26+musculoskeletal+diseases+open&rft.au=Sun%2C+Ruijie&rft.au=Liu%2C+Zheng&rft.au=Lu%2C+Hui&rft.au=Peng%2C+Yu&rft.date=2023-02-01&rft.issn=2056-5933&rft.eissn=2056-5933&rft.volume=9&rft.issue=1&rft.spage=e002865&rft_id=info:doi/10.1136%2Frmdopen-2022-002865&rft.externalDBID=n%2Fa&rft.externalDocID=10_1136_rmdopen_2022_002865 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2056-5933&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2056-5933&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2056-5933&client=summon |